Search results for "CORONARY ARTERY"

showing 10 items of 693 documents

Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction…

2006

Background— Individual markers of inflammation may add incremental predictive value in the context of conventionally available risk factors. We evaluated the ability of 9 inflammatory biomarkers, microalbuminuria, and N-terminal pro-brain natriuretic peptide (Nt-proBNP) to improve cardiovascular risk prediction beyond that obtained from traditional risk factors in a secondary-prevention population. Methods and Results— We measured biomarkers representing the acute-phase reaction (C-reactive protein, fibrinogen, and interleukin-6), proinflammatory pathways (soluble tumor necrosis factor receptor-1 and -2, soluble interleukin-1 receptor antagonist, and interleukin-18), endothelial activation…

MaleOncologymedicine.medical_specialtyHeart Diseasesmedicine.drug_classPopulationMyocardial InfarctionAngiotensin-Converting Enzyme InhibitorsContext (language use)Coronary Artery DiseaseProinflammatory cytokineEndothelial activationRamiprilPredictive Value of TestsRisk FactorsPhysiology (medical)Internal medicineNatriuretic Peptide BrainNatriuretic peptideHumansVitamin EMedicineRisk factoreducationAgededucation.field_of_studyInterleukin-6business.industryFibrinogenMiddle Agedmedicine.diseaseBrain natriuretic peptideC-Reactive ProteinEndocrinologyFemaleMicroalbuminuriaCardiology and Cardiovascular MedicinebusinessBiomarkers
researchProduct

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and manag…

2018

Abstract The primary purpose of these practical guidelines related to Kawasaki disease (KD) is to contribute to prompt diagnosis and appropriate treatment on the basis of different specialists’ contributions in the field. A set of 40 recommendations is provided, divided in two parts: the first describes the definition of KD, its epidemiology, etiopathogenetic hints, presentation, clinical course and general management, including treatment of the acute phase, through specific 23 recommendations. Their application is aimed at improving the rate of treatment with intravenous immunoglobulin and the overall potential development of coronary artery abnormalities in KD. Guidelines, however, should…

MalePediatricsReviewPediatricsSeverity of Illness Index0302 clinical medicineRetrospective StudieEpidemiology030212 general & internal medicineDisease management (health)Coronary artery abnormalitieChildrenSocieties MedicalRandomized Controlled Trials as TopicPediatriclcsh:RJ1-570Disease ManagementImmunoglobulins IntravenousGeneral MedicinePrognosisSettore MED/38Treatment OutcomeSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAItalyMeta-analysisAcute DiseasePractice Guidelines as TopicDisease ProgressionFemaleCoronary artery abnormalitiesAspirin; Children; Coronary artery abnormalities; Intravenous immunoglobulin; Kawasaki disease;Humanmedicine.medical_specialtyPrognosiMucocutaneous Lymph Node SyndromeRisk Assessment03 medical and health sciences030225 pediatricsSeverity of illnessmedicineHumansRisk factorIntravenous immunoglobulinRetrospective Studiesaspirin; children; coronary artery abnormalities; intravenous immunoglobulin; Kawasaki disease; pediatrics perinatology and child healthAspirinKawasaki diseasebusiness.industrylcsh:PediatricsRetrospective cohort studymedicine.diseaseImmunoglobulins IntravenouPediatrics Perinatology and Child Healthperinatology and child healthKawasaki diseaseDifferential diagnosisbusiness
researchProduct

Temporal trends in the premorbid use of preventive treatments in patients with acute ischemic cerebrovascular events and a history of vascular diseas…

2017

Although secondary prevention in patients with arterial vascular diseases has improved, a gap between recommendations and clinical practice may exist.We aimed to evaluate temporal trends in the premorbid use of preventive treatments in patients with ischemic cerebrovascular events (ICVE) and prior vascular disease.Patients with acute ICVE (ischemic stroke/TIA) were identified through the population-based stroke registry of Dijon, France (1985-2010). Only those with history of arterial vascular disease were included and were classified into four groups: patients with previous coronary artery disease only (CAD), previous peripheral artery disease only (PAD), previous ICVE only, and patients w…

MalePediatricsmedicine.medical_specialtyStroke registryTime FactorsPopulationCoronary Artery DiseaseDisease030204 cardiovascular system & hematologyLogistic regressionCoronary artery diseasePeripheral Arterial Disease03 medical and health sciences0302 clinical medicineFibrinolytic Agents[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineSecondary PreventionmedicineHumansIn patientProspective StudiesRegistrieseducationAntihypertensive AgentsComputingMilieux_MISCELLANEOUSAgedAged 80 and overSecondary preventioneducation.field_of_studyVascular diseasebusiness.industryGeneral MedicineMiddle Agedmedicine.disease3. Good healthStrokeFemaleFrancebusiness030217 neurology & neurosurgery
researchProduct

Cardiovascular responses to dynamic and static upper-body exercise in a cold environment in coronary artery disease patients

2021

Abstract Purpose Upper-body exercise performed in a cold environment may increase cardiovascular strain, which could be detrimental to patients with coronary artery disease (CAD). This study compared cardiovascular responses of CAD patients during graded upper-body dynamic and static exercise in cold and neutral environments. Methods 20 patients with stable CAD performed 30 min of progressive dynamic (light, moderate, and heavy rating of perceived exertion) and static (10, 15, 20, 25 and 30% of maximal voluntary contraction) upper body exercise in cold (− 15 °C) and neutral (+ 22 °C) environments. Heart rate (HR), blood pressure (BP) and electrocardiographic (ECG) responses were recorded an…

MalePhysiologyHemodynamicsBlood PressureCoronary artery diseaseCoronary artery diseaseElectrocardiographyOrthopedics and Sports MedicineTEMPERATUREStaticRating of perceived exertionST depressionVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801kuntoliikuntaGeneral MedicineMiddle AgedCold TemperatureHEMODYNAMICSCardiologykylmyysARMOriginal ArticleFemalemedicine.symptomCardiac function curvemedicine.medical_specialtyfyysinen rasitusDynamicHEART-RATEPhysiology (medical)Internal medicineHeart ratemedicineHumansEXPOSUREExerciseLEGbusiness.industryPublic Health Environmental and Occupational HealthUpper bodymedicine.diseasefyysinen kuormittavuusBlood pressureRate pressure productsepelvaltimotautiSNOWsydän- ja verisuonitauditVDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801businessCold
researchProduct

Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwentsurgical reperfusion: a randomized double-…

2007

Background: The inflammatory cascade has been hypothesized to be an important mechanism of post-ischaemic myocardial reperfusion injury and several studies demonstrated that C1 esterase inhibitor (C1 -INH) is effective in post-ischaemia myocardial protection. Therefore, we aimed to investigate prospectively in a randomised double-blind study the cardioprotective effects of C1-INH in ST segment elevation myocardial infarction (STEMI) in patients who underwent emergent reperfusion with coronary artery bypass grafting (CABG). Methods: In this study, we enrolled 80 patients affected with STEMI who underwent emergent CABG. Patients were assigned in two groups (C1-INH group: receive 1000 Ul of C1…

MalePulmonary and Respiratory MedicineCardiac function curvemedicine.medical_specialtyMean arterial pressureCardiotonic AgentsMyocardial InfarctionCardiac indexMyocardial ReperfusionComplement C1 Inactivator ProteinsCoronary artery bypass surgeryReperfusion therapyDouble-Blind MethodInternal medicinemedicineHumansProspective StudiesMyocardial infarctionCoronary Artery BypassInfusions IntravenousSTEMI patients CABG C1 esterase inhibitor Reperfusion injury Complement cascade Myocardial function recoverybusiness.industryST elevationTroponin IComplement C4aGeneral MedicineMiddle Agedmedicine.diseaseMyocardial ContractionComplement Inactivating AgentsTreatment OutcomeComplement C3aCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessReperfusion injury
researchProduct

Off-pump versus on-pump myocardial revascularization in patients with ST-segment elevation myocardial infarction: A randomized trial

2009

Objective Conventional cardioplegic arrest coronary artery bypass grafting after ST-segment elevation myocardial infarction is associated with high mortality and morbidity. The benefits of off-pump surgery have been suggested. This study randomly evaluated the impact of the off-pump technique on clinical results. Methods Between February 2002 and October 2007, 128 patients with ST-segment elevation myocardial infarction who underwent myocardial revascularization within 48 hours from the onset of symptoms were randomly assigned to 2 groups: on-pump group (66 patients/51.5%) and off-pump group (63 patients/48.5%). The primary end point was the incidence of in-hospital death and outcomes (low …

MalePulmonary and Respiratory MedicineCardiac function curvemedicine.medical_specialtyTime FactorsOff-pump myocardial revascularization on-pump myocardial revascularization ST-segment elevation myocardial infarctionmedicine.medical_treatmentCoronary Artery Bypass Off-PumpMyocardial Infarctionlaw.inventionlawInternal medicineMyocardial RevascularizationCardiopulmonary bypassHumansMedicineMyocardial infarctionAgedbusiness.industryCardiogenic shockST elevationPercutaneous coronary interventionPerioperativeMiddle Agedmedicine.diseaseIntensive care unitCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Minimally invasive coronary artery bypass grafting via a lower ministernotomy for left anterior descending artery myocardial bridging: mid-term resul…

2021

Abstract OBJECTIVES Coronary artery bypass grafting or supra-arterial myotomy is now suggested as a better therapeutic option in myocardial bridging (MB) when medical treatment fails to control symptoms. For left anterior descending (LAD) MB, minimally invasive coronary artery bypass via a lower ministernotomy can be offered. METHODS Forty-four consecutive patients who underwent elective minimally invasive coronary artery bypass surgery from 2005 to 2014 via an inferior sternotomy using the left internal mammary artery as a bypass graft for LAD MB were evaluated retrospectively. RESULTS The mean age was 59.1 ± 13.1 years with 26 (59%) men and 18 (41%) women. The mean body mass index was 27.…

MalePulmonary and Respiratory MedicineMyotomyCanadamedicine.medical_specialtyMyocardial bridgingMyocardial Bridgingmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciencesCoronary artery bypass surgery0302 clinical medicinemedicineHumansMinimally Invasive Surgical ProceduresCoronary Artery BypassMammary ArteriesAgedRetrospective StudiesAdult Cardiacmedicine.diagnostic_testbusiness.industryCanadian Cardiovascular SocietyMiddle AgedSurgeryTreatment Outcomemedicine.anatomical_structure030228 respiratory systemAngiographyFemaleSurgeryCardiology and Cardiovascular MedicineComplicationbusinessBody mass indexArteryInteractive CardioVascular and Thoracic Surgery
researchProduct

Coronary artery bypass grafting in adult coronary artery disease due to suspected Kawasaki disease in childhood

2000

Development of coronary artery aneurysms is one typical complication of Kawasaki disease and can cause coronary artery disease even in early childhood. Information about course and outcome in adults is rare. Here, we present a 49-year-old man with serious three-vessel coronary artery disease and giant coronary artery aneurysms following suspected Kawasaki disease.

MalePulmonary and Respiratory MedicineSystemic diseasemedicine.medical_specialtyCoronary DiseaseMucocutaneous Lymph Node SyndromeCoronary artery diseaseAneurysmhemic and lymphatic diseasesInternal medicinemedicineHumanscardiovascular diseasesCoronary Artery BypassVascular diseasebusiness.industryCoronary AneurysmMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structurecardiovascular systemCardiologySurgeryKawasaki diseaseCardiology and Cardiovascular MedicinebusinessComplicationVasculitisArteryThe Annals of Thoracic Surgery
researchProduct

Bridge to Operation with the GPIIb/IIIa Inhibitor Abciximab in High-Risk Coronary Patients

2006

BACKGROUND Glycoprotein-IIb/IIIa inhibitors are now frequently used in the cardiological treatment of high-risk coronary patients even if the patient is considered suitable for surgical intervention. However, there is no consensus whether GPIIb/IIIa inhibitors should be stopped before operation because of an increased risk of bleeding or if surgery should even be delayed until the anticoagulating effect subsides. METHODS From June 2002 to August 2003 140 patients who had to undergo primary aorto-coronary bypass for ongoing myocardial ischemia were enrolled in the present study. The patients received either clopidogrel, aspirin and heparin or additionally abciximab until operation. RESULTS A…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyAbciximabMyocardial InfarctionHemodynamicsCoronary DiseasePlatelet Glycoprotein GPIIb-IIIa ComplexImmunoglobulin Fab FragmentsGpIIb/IIIaRisk FactorsInternal medicinemedicineAbciximabHumansProspective StudiesRegistriesCoronary Artery BypassAgedAspirinbusiness.industryIncidence (epidemiology)Antibodies MonoclonalHeparinMiddle AgedClopidogrelSurvival AnalysisHemostasis SurgicalTreatment OutcomeBridge (graph theory)Elective Surgical ProceduresCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation InhibitorsFollow-Up Studiesmedicine.drugThe Thoracic and Cardiovascular Surgeon
researchProduct

Extrathoracic Arteriosclerotic Vascular Changes Preclude the Use of the Internal Thoracic Artery for Coronary Artery Bypass Grafting

1996

During a two-years period we have treated 6 patients where use of the internal thoracic artery for coronary artery grafting was precluded because of extrathoracic arteriosclerotic vascular lesions. In four patients with severe aorto-iliac occlusive disease preoperative digital angiography demonstrated collateralisation of the lower extremity by either the left, right, or both internal thoracic arteries (ITA). In these cases use of the ITA was excluded in order to preserve the collateral supply and coronary bypass grafting was performed using only saphenous vein. In two patients with proximal occlusion of the left subclavian artery the right ITA was used as in-situ bypass to graft the left a…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyBypass graftingOcclusive diseaseCollateral CirculationCoronary Artery DiseaseInternal thoracic arteryPostoperative ComplicationsThoracic ArteriesIschemiaRisk FactorsInternal medicinemedicine.arteryOcclusionmedicineHumansSaphenous VeinMyocardial infarctionCoronary Artery BypassVeinAgedLegbusiness.industryAngiography Digital SubtractionPerioperativemedicine.diseasemedicine.anatomical_structureCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessArteryThe Thoracic and Cardiovascular Surgeon
researchProduct